Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 88

1.

Evaluation of SUMO1 and POU2AF1 in whole blood from rheumatoid arthritis patients and at risk relatives.

Romo-García MF, Nava-Ramírez HS, Zapata-Zúñiga M, Macías-Segura N, Santiago-Algarra D, Castillo-Ortiz JD, Bastián Y, Ramos-Remus C, Enciso-Moreno JA, Castañeda-Delgado JE.

Int J Immunogenet. 2019 Jan 25. doi: 10.1111/iji.12414. [Epub ahead of print]

PMID:
30681271
2.

Potential uses of an infodemiology approach for health-care services for rheumatology.

Martinez-Arroyo G, Ramos-Gomez S, Rojero-Gil EK, Rojas-Gongora JA, Barajas-Ochoa A, Bustamante-Montes LP, Yañez J, Ramos-Remus C.

Clin Rheumatol. 2018 Nov 17. doi: 10.1007/s10067-018-4364-z. [Epub ahead of print]

PMID:
30448932
3.

Assessment of SpondyloArthritis International Society (ASAS) Consensus on Spanish Nomenclature for Spondyloarthritis.

Navarro-Compán V, Otón T, Loza E, Almodóvar R, Ariza-Ariza R, Bautista-Molano W, Burgos-Vargas R, Collantes-Estévez E, de Miguel E, González-Fernández C, Gratacós J, Ibáñez S, Juanola X, Maldonado-Cocco J, Moltó A, Mulero J, Pacheco-Tena C, Ramos-Remus C, Sanz-Sanz J, Valle-Oñate R, Zarco P, Marzo-Ortega H.

Reumatol Clin. 2018 Sep 4. pii: S1699-258X(18)30173-6. doi: 10.1016/j.reuma.2018.07.014. [Epub ahead of print] English, Spanish.

4.

Analysis of miRNA expression in patients with rheumatoid arthritis during remission and relapse after a 5-year trial of tofacitinib treatment.

Fernández-Ruiz JC, Ramos-Remus C, Sánchez-Corona J, Castillo-Ortiz JD, Castañeda-Sánchez JJ, Bastian Y, Romo-García MF, Ochoa-González F, Monsivais-Urenda AE, González-Amaro R, Enciso-Moreno JA, Castañeda-Delgado JE.

Int Immunopharmacol. 2018 Oct;63:35-42. doi: 10.1016/j.intimp.2018.07.028. Epub 2018 Jul 31.

PMID:
30075427
5.

Trends of Informed Consent forms for industry-sponsored clinical trials in rheumatology over a 17-year period: Readability, and assessment of patients' health literacy and perceptions.

de la Mora-Molina H, Barajas-Ochoa A, Sandoval-Garcia L, Navarrete-Lorenzon M, Castañeda-Barragan EA, Castillo-Ortiz JD, Aceves-Avila FJ, Yañez J, Bustamante-Montes LP, Ramos-Remus C.

Semin Arthritis Rheum. 2018 Dec;48(3):547-552. doi: 10.1016/j.semarthrit.2018.03.008. Epub 2018 Mar 16.

PMID:
29724453
6.

Transcriptional signature associated with early rheumatoid arthritis and healthy individuals at high risk to develop the disease.

Macías-Segura N, Castañeda-Delgado JE, Bastian Y, Santiago-Algarra D, Castillo-Ortiz JD, Alemán-Navarro AL, Jaime-Sánchez E, Gomez-Moreno M, Saucedo-Toral CA, Lara-Ramírez EE, Zapata-Zuñiga M, Enciso-Moreno L, González-Amaro R, Ramos-Remus C, Enciso-Moreno JA.

PLoS One. 2018 Mar 27;13(3):e0194205. doi: 10.1371/journal.pone.0194205. eCollection 2018.

7.

[Equity, validity and reliability of the National Examination for Candidates to Medical Residences (ENARM): opportunities for improvement].

Barajas-Ochoa A, Ramos-Remus C.

Salud Publica Mex. 2017 Sep-Oct;59(5):501-502. doi: 10.21149/8769. Spanish. No abstract available.

8.

Is gout an easy-to-treat disease? The importance of health determinants.

Barajas-Ochoa A, Castaneda-Sanchez JJ, Ramos-Remus C.

Reumatol Clin. 2018 Jan - Feb;14(1):59-60. doi: 10.1016/j.reuma.2017.03.008. Epub 2017 Apr 12. English, Spanish. No abstract available.

9.

Type I Interferon Gene Response Is Increased in Early and Established Rheumatoid Arthritis and Correlates with Autoantibody Production.

Castañeda-Delgado JE, Bastián-Hernandez Y, Macias-Segura N, Santiago-Algarra D, Castillo-Ortiz JD, Alemán-Navarro AL, Martínez-Tejada P, Enciso-Moreno L, Garcia-De Lira Y, Olguín-Calderón D, Trouw LA, Ramos-Remus C, Enciso-Moreno JA.

Front Immunol. 2017 Mar 20;8:285. doi: 10.3389/fimmu.2017.00285. eCollection 2017.

10.

Baricitinib, Methotrexate, or Combination in Patients With Rheumatoid Arthritis and No or Limited Prior Disease-Modifying Antirheumatic Drug Treatment.

Fleischmann R, Schiff M, van der Heijde D, Ramos-Remus C, Spindler A, Stanislav M, Zerbini CA, Gurbuz S, Dickson C, de Bono S, Schlichting D, Beattie S, Kuo WL, Rooney T, Macias W, Takeuchi T.

Arthritis Rheumatol. 2017 Mar;69(3):506-517. doi: 10.1002/art.39953.

11.

Fifteen-year trend in information on the World Wide Web for patients with rheumatoid arthritis: evolving, but opportunities for improvement remain.

Castillo-Ortiz JD, de Jesus Valdivia-Nuno J, Ramirez-Gomez A, Garagarza-Mariscal H, Gallegos-Rios C, Flores-Hernandez G, Hernandez-Sanchez L, Brambila-Barba V, Castaneda-Sanchez JJ, Barajas-Ochoa Z, Suarez-Rico A, Sanchez-Gonzalez JM, Ramos-Remus C.

Rheumatol Int. 2016 Sep;36(9):1281-9. doi: 10.1007/s00296-016-3507-2. Epub 2016 Jun 13.

PMID:
27295190
12.

Readability, relevance and quality of the information in Spanish on the Web for patients with rheumatoid arthritis.

Castillo-Ortiz JD, Valdivia-Nuno JJ, Ramirez-Gomez A, Garagarza-Mariscal H, Gallegos-Rios C, Flores-Hernandez G, Hernandez-Sanchez L, Brambila-Barba V, Castaneda-Sanchez JJ, Barajas-Ochoa Z, Suarez-Rico A, Sanchez-Gonzalez JM, Ramos-Remus C.

Reumatol Clin. 2017 May - Jun;13(3):139-144. doi: 10.1016/j.reuma.2016.04.009. Epub 2016 May 31. English, Spanish.

13.

[Reforming the Ross' triangle: new challenges for the medical excellence].

Garagarza-Mariscal H, Castillo-Ortiz JD, Ramos-Remus C.

Gac Med Mex. 2016 Mar-Apr;152(2):275-7. Spanish. No abstract available.

14.

Autoantibodies in prediction of the development of rheumatoid arthritis among healthy relatives of patients with the disease.

Ramos-Remus C, Castillo-Ortiz JD, Aguilar-Lozano L, Padilla-Ibarra J, Sandoval-Castro C, Vargas-Serafin CO, de la Mora-Molina H, Ramos-Gomez A, Sanchez-Ortiz A, Avila-Armengol H, Aceves-Avila FJ.

Arthritis Rheumatol. 2015 Nov;67(11):2837-44. doi: 10.1002/art.39297.

15.

Divergent perceptions in health-related quality of life between family members and patients with rheumatoid arthritis, systemic lupus erythematosus, and ankylosing spondylitis.

Ramos-Remus C, Castillo-Ortiz JD, Sandoval-Castro C, Paez-Agraz F, Sanchez-Ortiz A, Aceves-Avila FJ.

Rheumatol Int. 2014 Dec;34(12):1743-9. doi: 10.1007/s00296-014-3044-9. Epub 2014 May 24.

PMID:
24859395
16.

The number needed to offend: a cross-sectional study of potential offensiveness of rheumatic diagnostic labels.

Castillo-Ortiz JD, Russell AS, Davis P, Vargas-Serafin CO, Ramirez-Gomez A, Aceves-Avila FJ, De la Mora-Molina H, Gonzalez-Leija ME, Pacheco-Lorenzo R, Ramos-Remus C.

Clin Rheumatol. 2014 Apr;33(4):561-6. doi: 10.1007/s10067-013-2407-z. Epub 2013 Oct 10.

PMID:
24114394
17.

Temporomandibular joint dysfunction in various rheumatic diseases.

Aceves-Avila FJ, Chávez-López M, Chavira-González JR, Ramos-Remus C.

Reumatismo. 2013 Jul 24;65(3):126-30. doi: 10.4081/reumatismo.2013.126.

PMID:
23884028
18.

Sustained clinical remission and rate of relapse after tocilizumab withdrawal in patients with rheumatoid arthritis.

Aguilar-Lozano L, Castillo-Ortiz JD, Vargas-Serafin C, Morales-Torres J, Sanchez-Ortiz A, Sandoval-Castro C, Padilla-Ibarra J, Hernandez-Cuevas C, Ramos-Remus C.

J Rheumatol. 2013 Jul;40(7):1069-73. doi: 10.3899/jrheum.121427. Epub 2013 Jun 1.

PMID:
23729804
19.

Rituximab treatment for pulmonary arterial hypertension in adult-onset Still's disease.

Padilla-Ibarra J, Sanchez-Ortiz A, Sandoval-Castro C, Ramos-Remus C.

Clin Exp Rheumatol. 2013 Jul-Aug;31(4):657-8. Epub 2013 Apr 22. No abstract available.

PMID:
23622421
20.

Catastrophic health expenses and impoverishment of households of patients with rheumatoid arthritis.

Álvarez-Hernández E, Peláez-Ballestas I, Boonen A, Vázquez-Mellado J, Hernández-Garduño A, Rivera FC, Teran-Estrada L, Ventura-Ríos L, Ramos-Remus C, Skinner-Taylor C, Goycochea-Robles MV, Bernard-Medina AG, Burgos-Vargas R.

Reumatol Clin. 2012 Jul-Aug;8(4):168-73. doi: 10.1016/j.reuma.2012.05.002. Epub 2012 Jun 15.

21.

Clinical efficacy of etanercept versus sulfasalazine in ankylosing spondylitis subjects with peripheral joint involvement.

Braun J, Pavelka K, Ramos-Remus C, Dimic A, Vlahos B, Freundlich B, Koenig AS.

J Rheumatol. 2012 Apr;39(4):836-40. doi: 10.3899/jrheum.110885. Epub 2012 Feb 15.

PMID:
22337244
22.

Cost of medication errors in rheumatic patients in Mexico.

Aceves-Avila FJ, Benites-Godínez V, Ramos-Remus C.

Clin Rheumatol. 2011 Nov;30(11):1421-4. doi: 10.1007/s10067-011-1837-8. Epub 2011 Sep 21.

PMID:
21947700
23.

Beyond the joints: neurological involvement in rheumatoid arthritis.

Ramos-Remus C, Duran-Barragan S, Castillo-Ortiz JD.

Clin Rheumatol. 2012 Jan;31(1):1-12. doi: 10.1007/s10067-011-1841-z. Epub 2011 Sep 20. Review.

PMID:
21932019
24.

[Anti-transglutaminase, antigladin and ultra purified anti-gladin antibodies in patients with a diagnosis of rheumatoid arthritis].

Castillo-Ortiz JD, Durán-Barragán S, Sánchez-Ortíz A, Ramos-Remus C.

Reumatol Clin. 2011 Jan-Feb;7(1):27-9. doi: 10.1016/j.reuma.2010.03.006. Epub 2010 Jun 23. Spanish.

25.

Fifteen-year trends of long-term disability and sick leaves in ankylosing spondylitis.

Ramos-Remus C, Hernandez-Rios G, Duran-Barragan S, Sanchez-Ortiz A, Aceves-Avila FJ, Castillo-Ortiz JD, Gonzalez-Perez O.

Clin Rheumatol. 2011 Mar;30(3):361-7. doi: 10.1007/s10067-010-1669-y. Epub 2011 Jan 6.

PMID:
21210289
26.

Dissemination and evaluation of the 3E initiative recommendations for use of methotrexate in rheumatic disorders: results of a study among 2233 rheumatologists.

Gossec L, Bijlsma JW, Bombardier C, Canhão H, Devlin J, Edwards CJ, Hamuryudan V, Kvien TK, Leeb BF, Martín-Mola EM, Mielants H, Müller-Ladner U, Ostergaard M, Pereira IA, Ramos-Remus C, Zochling J, Dougados M.

Ann Rheum Dis. 2011 Feb;70(2):388-9. doi: 10.1136/ard.2010.128652. Epub 2010 May 14. No abstract available.

PMID:
20472594
27.

Autonomic dysfunction in fibromyalgia assessed by the Composite Autonomic Symptoms Scale (COMPASS).

Solano C, Martinez A, Becerril L, Vargas A, Figueroa J, Navarro C, Ramos-Remus C, Martinez-Lavin M.

J Clin Rheumatol. 2009 Jun;15(4):172-6. doi: 10.1097/RHU.0b013e3181a1083d.

PMID:
19342959
28.

Multinational evidence-based recommendations for the use of methotrexate in rheumatic disorders with a focus on rheumatoid arthritis: integrating systematic literature research and expert opinion of a broad international panel of rheumatologists in the 3E Initiative.

Visser K, Katchamart W, Loza E, Martinez-Lopez JA, Salliot C, Trudeau J, Bombardier C, Carmona L, van der Heijde D, Bijlsma JW, Boumpas DT, Canhao H, Edwards CJ, Hamuryudan V, Kvien TK, Leeb BF, Martín-Mola EM, Mielants H, Müller-Ladner U, Murphy G, Østergaard M, Pereira IA, Ramos-Remus C, Valentini G, Zochling J, Dougados M.

Ann Rheum Dis. 2009 Jul;68(7):1086-93. doi: 10.1136/ard.2008.094474. Epub 2008 Nov 25.

29.

Recurrent urinary tract infections and bladder dysfunction in systemic lupus erythematosus.

Duran-Barragan S, Ruvalcaba-Naranjo H, Rodriguez-Gutierrez L, Solano-Moreno H, Hernandez-Rios G, Sanchez-Ortiz A, Ramos-Remus C.

Lupus. 2008 Dec;17(12):1117-21. doi: 10.1177/0961203308093458.

PMID:
19029280
30.

Tendinous and ligamentous derangements in systemic lupus erythematosus.

Sierra-Jimenez G, Sanchez-Ortiz A, Aceves-Avila FJ, Hernandez-Rios G, Durán-Barragán S, Ramos-Remus C.

J Rheumatol. 2008 Nov;35(11):2187-91. Epub 2008 Sep 1.

PMID:
18785311
31.

Complementary and alternative practices in rheumatology.

Ramos-Remus C, Raut A.

Best Pract Res Clin Rheumatol. 2008 Aug;22(4):741-57. doi: 10.1016/j.berh.2008.05.001. Review.

PMID:
18783748
32.

[Social costs of the most common inflammatory rheumatic diseases in Mexico from the patient's perspective].

Mould-Quevedo J, Peláez-Ballestas I, Vázquez-Mellado J, Terán-Estrada L, Esquivel-Valerio J, Ventura-Ríos L, Aceves-Avila FJ, Bernard-Medina AG, Goycochea-Robles MV, Hernández-Garduño A, Burgos-Vargas R, Shumski C, Garza-Elizondo M, Ramos-Remus C, Espinoza-Villalpando J, Alvarez-Hernández E, Flores-Alvarado D, Rodríguez-Amado J, Casasola-Vargas J, Skinner-Taylor C; Grupo REUMAIMPACT.

Gac Med Mex. 2008 May-Jun;144(3):225-31. Spanish.

PMID:
18714591
33.

Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial.

Smolen JS, Beaulieu A, Rubbert-Roth A, Ramos-Remus C, Rovensky J, Alecock E, Woodworth T, Alten R; OPTION Investigators.

Lancet. 2008 Mar 22;371(9617):987-97. doi: 10.1016/S0140-6736(08)60453-5.

PMID:
18358926
34.

Deflazacort: a glucocorticoid with few metabolic adverse effects but important immunosuppressive activity.

Gonzalez-Perez O, Luquin S, Garcia-Estrada J, Ramos-Remus C.

Adv Ther. 2007 Sep-Oct;24(5):1052-60. Review.

PMID:
18029332
35.

Latitude gradient influences the age of onset in rheumatoid arthritis patients.

Ramos-Remus C, Sierra-Jimenez G, Skeith K, Aceves-Avila FJ, Russell AS, Offer R, Olguin-Redes JE, Homik J, Sanchez L, Sanchez-Ortiz A, Navarro-Cano G.

Clin Rheumatol. 2007 Oct;26(10):1725-8. Epub 2007 Jul 24.

PMID:
17646901
36.

Los tratamientos no convencionales y las terapias alternativas en la era de grandes avances terapéuticos en reumatología.

Hernández Ríos G, Durán Barragán S, Ramos-Remus C.

Reumatol Clin. 2006 Jul;2(4):161-3. doi: 10.1016/S1699-258X(06)73040-6. Epub 2008 Dec 10. Spanish. No abstract available.

37.

Deflazacort induced stronger immunosuppression than expected.

Gonzalez-Castañeda RE, Castellanos-Alvarado EA, Flores-Marquez MR, Gonzalez-Perez O, Luquin S, Garcia-Estrada J, Ramos-Remus C.

Clin Rheumatol. 2007 Jun;26(6):935-40.

PMID:
16738843
38.

Evaluation of the efficacy of etoricoxib in ankylosing spondylitis: results of a fifty-two-week, randomized, controlled study.

van der Heijde D, Baraf HS, Ramos-Remus C, Calin A, Weaver AL, Schiff M, James M, Markind JE, Reicin AS, Melian A, Dougados M.

Arthritis Rheum. 2005 Apr;52(4):1205-15.

39.

A randomised, placebo controlled, comparative trial of the gastrointestinal safety and efficacy of AZD3582 versus naproxen in osteoarthritis.

Lohmander LS, McKeith D, Svensson O, Malmenäs M, Bolin L, Kalla A, Genti G, Szechinski J, Ramos-Remus C; STAR Multinational Study Group.

Ann Rheum Dis. 2005 Mar;64(3):449-56. Epub 2004 Sep 2.

40.

Cyclophosphamide boluses induce micronuclei expression in buccal mucosa cells of patients with systemic lupus erythematosus independent of cytochrome P450 2D6 status.

Aceves Avila FJ, Esquivel Nava GA, Gallegos Arreola MP, Gómez Meda B, Zúñiga González G, Ramos-Remus C.

J Rheumatol. 2004 Jul;31(7):1335-9.

PMID:
15229952
41.
42.

New insights into culture driven disorders.

Aceves-Avila FJ, Ferrari R, Ramos-Remus C.

Best Pract Res Clin Rheumatol. 2004 Apr;18(2):155-71. Review.

PMID:
15121037
43.

Validation of the Spanish version of a screening questionnaire for the detection of systemic lupus erythematosus.

Aceves-Avila FJ, Delgadillo-Ruano MA, Ramos-Remus C, Gómez-Vargas A, Gutiérrez-Ureña S.

Clin Rheumatol. 2003 Dec;22(6):400-4. Epub 2003 Nov 11.

PMID:
14677015
44.

[Effect of ramipril on the glucose/insulin coefficient and the ventricular mass index in patients with light to moderate arterial hypertension].

Germán Cardona-Muñoz E, Noriega-Arellano J, Hernández-Chávez A, López-Alvarado A, González-Ortiz M, Martínez-Abundis E, Delgado Hurtado JM, Ramos-Remus C, Gamez-Nava I, Ayub-Ayala M.

Arch Cardiol Mex. 2003 Jan-Mar;73(1):24-30. Spanish.

PMID:
12820491
45.

The first descriptions of therapeutic arthrocentesis: a historical note.

Aceves-Avila FJ, Delgadillo-Ruano MA, Ramos-Remus C, Gómez-Vargas A, Gutiérrez-Ureña S.

Rheumatology (Oxford). 2003 Jan;42(1):180-3.

PMID:
12509634
46.

Prednisone induces cognitive dysfunction, neuronal degeneration, and reactive gliosis in rats.

Ramos-Remus C, González-Castañeda RE, González-Perez O, Luquin S, García-Estrada J.

J Investig Med. 2002 Nov;50(6):458-64. doi: 10.1136/jim-50-06-06.

PMID:
12425433
47.

[The "Hospital Real de San Josef de los Naturales" and the rheumatic conditions found in New Spain during the 16th century].

Aceves-Avila FJ, Delgadillo-Ruano MA, Ramos-Remus C, Gómez-Vargas A.

Reumatismo. 2002;54(1):62-6. Italian.

48.

Genotoxicity assessment using micronuclei assay in rheumatoid arthritis patients.

Ramos-Remus C, Dorazco-Barragan G, Aceves-Avila FJ, Alcaraz-Lopez F, Fuentes-Ramirez F, Michel-Diaz J, Torres-Bugarin O, Ventura-Aguilar A, Zuñiga-González G.

Clin Exp Rheumatol. 2002 Mar-Apr;20(2):208-12.

PMID:
12051400
49.

Prednisone induces anxiety and glial cerebral changes in rats.

Gonzalez-Perez O, Ramos-Remus C, Garcia-Estrada J, Luquin S.

J Rheumatol. 2001 Nov;28(11):2529-34.

PMID:
11708428
50.

Images in clinical medicine. A hair-on-end skull.

Ramos-Remus C, Galvan-Villegas F.

N Engl J Med. 2001 Aug 2;345(5):e1. No abstract available.

Supplemental Content

Loading ...
Support Center